HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Bitzer Selected Research

Gemcitabine

10/2020CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results.
3/2009[Thrombotic microangiopathy under an effective treatment with gemcitabine].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Bitzer Research Topics

Disease

10Neoplasms (Cancer)
12/2021 - 10/2000
5Hepatocellular Carcinoma (Hepatoma)
03/2022 - 11/2001
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 03/2009
3Adenocarcinoma
10/2020 - 10/2016
2Thrombocytopenia (Thrombopenia)
10/2020 - 03/2009
2Inflammation (Inflammations)
01/2018 - 09/2000
2Infections
01/2018 - 11/2004
2Carcinoma (Carcinomatosis)
01/2018 - 08/2013
2Neoplasm Metastasis (Metastasis)
10/2016 - 02/2014
2Edema (Dropsy)
05/2001 - 10/2000
1Neutropenia
10/2020
1Fatigue
10/2020
1Hypertension (High Blood Pressure)
10/2020
1Chronic Pain
01/2018
1Esophageal Neoplasms (Esophageal Cancer)
01/2018
1Weight Loss (Weight Reduction)
02/2014
1Jaundice (Icterus)
02/2014
1Acinar Cell Carcinoma
02/2014
1Leptospirosis
01/2014
1Ovarian Neoplasms (Ovarian Cancer)
08/2013
1Thrombotic Thrombocytopenic Purpura
03/2009
1Thrombotic Microangiopathies
03/2009
1Anemia
03/2009
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2004
1Residual Neoplasm
11/2004
1Vomiting
02/2004
1Pain (Aches)
02/2004
1Diarrhea
02/2004
1Priapism
12/2001
1Leukoencephalopathies
05/2001
1Brain Neoplasms (Brain Tumor)
05/2001
1Brain Edema (Cerebral Edema)
05/2001
1Meningioma (Meningiomas)
10/2000
1Hypertrophy
09/2000
1Myopia
01/2000
1Hyperopia (Hypermetropia)
01/2000
1Refractive Errors (Refractive Error)
01/2000

Drug/Important Bio-Agent (IBA)

2GemcitabineFDA Link
10/2020 - 03/2009
2Measles VaccineIBA
11/2013 - 08/2013
2ProdrugsIBA
08/2013 - 11/2001
1B7-H1 AntigenIBA
12/2021
1Sorafenib (BAY 43-9006)FDA Link
10/2020
1TransferasesIBA
10/2020
1Biomarkers (Surrogate Marker)IBA
01/2018
1Nucleic AcidsIBA
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1Fluorouracil (Carac)FDA LinkGeneric
10/2016
1Leucovorin (Folinic Acid)FDA Link
10/2016
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2016
1Docetaxel (Taxotere)FDA Link
10/2016
1folfirinoxIBA
02/2014
1BilirubinIBA
02/2014
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2014
1EnzymesIBA
08/2013
1uracil phosphoribosyltransferaseIBA
08/2013
1Cytosine DeaminaseIBA
08/2013
1Sunitinib (Sutent)FDA Link
07/2013
1ErbB Receptors (EGF Receptor)IBA
03/2012
1Trastuzumab (Herceptin)FDA Link
03/2012
1Capecitabine (Xeloda)FDA Link
03/2012
1thiamine triphosphorate (TTP)IBA
03/2009
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2009
1Peptide Hydrolases (Proteases)FDA Link
03/2009
1von Willebrand FactorIBA
03/2009
1CreatinineIBA
03/2009
1Cytostatic AgentsIBA
03/2009
1Rituximab (Mabthera)FDA Link
11/2004
1Doxycycline (Periostat)FDA LinkGeneric
02/2004
1Heparin (Liquaemin)FDA LinkGeneric
12/2001
1AntibodiesIBA
12/2001
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
05/2001
1Contrast MediaIBA
10/2000
1CytokinesIBA
09/2000
1Transforming Growth Factor beta (TGF-beta)IBA
09/2000
1Retinaldehyde (Retinal)IBA
01/2000

Therapy/Procedure

9Therapeutics
12/2021 - 11/2004
4Drug Therapy (Chemotherapy)
10/2016 - 11/2004
1Liver Transplantation
03/2022
1Neoadjuvant Therapy
01/2018
1Palliative Care (Palliative Therapy)
10/2016
1Fluid Therapy (Oral Rehydration Therapy)
01/2014
1Analgesia
01/2014
1Plasma Exchange
03/2009
1Stem Cell Transplantation
11/2004
1Chemoradiotherapy
05/2001
1Eye Protective Devices (Goggles)
01/2000
1Lenses
01/2000